Recurrence and cancer‐specific death after adjuvant chemotherapy for Stage III colon cancer
暂无分享,去创建一个
O. Dent | P. Chapuis | E. Bokey | C. Young | C. Chan | M. Rickard | A. Keshava | P. Stewart | Christopher J. Young | Christopher J. Young
[1] Shan Wang,et al. Is it time to define complete mesocolic excision as a standardized colon cancer surgery? , 2018, Translational gastroenterology and hepatology.
[2] S. Clemenceau,et al. Surgical technique , 2018, Neurophysiologie Clinique.
[3] O. Dent,et al. Long‐term results following an anatomically based surgical technique for resection of colon cancer: a comparison with results from complete mesocolic excision , 2016, Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland.
[4] L. Påhlman,et al. Should the Benefit of Adjuvant Chemotherapy in Colon Cancer Be Re-Evaluated? , 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[5] J. Church,et al. Primacy of surgery for colorectal cancer , 2015, The British journal of surgery.
[6] O. Dent,et al. Complications after resection of colorectal cancer in a public hospital and a private hospital , 2015, ANZ journal of surgery.
[7] J. E. Jansen,et al. Disease-free survival after complete mesocolic excision compared with conventional colon cancer surgery: a retrospective, population-based study. , 2015, The Lancet. Oncology.
[8] D. Winter,et al. Complete mesocolic resection and extended lymphadenectomy for colon cancer: a systematic review , 2014, Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland.
[9] N. Haboubi. Colonic surgery for cancer: a new paradigm , 2009, Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland.
[10] K. Matzel,et al. Standardized surgery for colonic cancer: complete mesocolic excision and central ligation – technical notes and outcome , 2009, Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland.
[11] B. Vonen,et al. Final results of a randomised phase III study on adjuvant chemotherapy with 5 FU and levamisol in colon and rectum cancer stage II and III by the Norwegian Gastrointestinal Cancer Group , 2009, Acta oncologica.
[12] D. Kerr,et al. Adjuvant chemotherapy versus observation in patients with colorectal cancer: a randomised study , 2007, The Lancet.
[13] R. Labianca,et al. Endpoints in adjuvant treatment trials: a systematic review of the literature in colon cancer and proposed definitions for future trials. , 2007, Journal of the National Cancer Institute.
[14] H Putter,et al. Tutorial in biostatistics: competing risks and multi‐state models , 2007, Statistics in medicine.
[15] H. Grönberg,et al. Adjuvant chemotherapy in colorectal cancer: A joint analysis of randomised trials by the Nordic Gastrointestinal Tumour Adjuvant Therapy Group , 2005, Acta oncologica.
[16] M. Kohli,et al. Re: Randomized trial of adjuvant therapy in colon carcinoma: 10-year results of NSABP protocol C-01. , 2004, Journal of the National Cancer Institute.
[17] J. Satagopan,et al. A note on competing risks in survival data analysis , 2004, British Journal of Cancer.
[18] D. Lowy,et al. Re: Specific Antibody Levels at the Cervix During the Menstrual Cycle of Women Vaccinated With Human Papillomavirus 16 Virus-Like Particles , 2004 .
[19] O. Dent,et al. Adverse histopathological findings as a guide to patient management after curative resection of node‐positive colonic cancer , 2004, The British journal of surgery.
[20] Marc Buyse,et al. Semimonthly versus monthly regimen of fluorouracil and leucovorin administered for 24 or 36 weeks as adjuvant therapy in stage II and III colon cancer: results of a randomized trial. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[21] O. Dent,et al. Surgical Technique and Survival in Patients Having a Curative Resection for Colon Cancer , 2003, Diseases of the colon and rectum.
[22] A. Piga,et al. The Role of Levamisole in the Adjuvant Treatment of Stage III Colon Cancer Patients: A Randomized Trial of 5-Fluorouracil and Levamisole Versus 5-Fluorouracil Alone , 2003, Cancer investigation.
[23] T. Wiggers,et al. Adjuvant 5FU plus levamisole in colonic or rectal cancer: improved survival in stage II and III , 2001, British Journal of Cancer.
[24] R. Porschen,et al. Fluorouracil plus leucovorin as effective adjuvant chemotherapy in curatively resected stage III colon cancer: results of the trial adjCCA-01. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[25] C. Wilson,et al. Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[26] J. Plukker,et al. The addition of low-dose leucovorin to the combination of 5-fluorouracillevamisole does not improve survival in the adjuvant treatment of Dukes' C colon cancer , 2000 .
[27] Robert Gray,et al. A Proportional Hazards Model for the Subdistribution of a Competing Risk , 1999 .
[28] H. Rockette,et al. Comparative efficacy of adjuvant chemotherapy in patients with Dukes' B versus Dukes' C colon cancer: results from four National Surgical Adjuvant Breast and Bowel Project adjuvant studies (C-01, C-02, C-03, and C-04) , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[29] J Crowley,et al. Estimation of failure probabilities in the presence of competing risks: new representations of old estimators. , 1999, Statistics in medicine.
[30] W. Scheithauer,et al. Combined intraperitoneal plus intravenous chemotherapy after curative resection for colonic adenocarcinoma. , 1995, European journal of cancer.
[31] J. P. Pignon,et al. Efficacy of adjuvant fluorouracil and folinic acid in colon cancer International Multicentre Pooled Analysis of Colon Cancer Trials (IMPACT) investigators , 1995, The Lancet.
[32] T. Reynolds. Dutch trial casts doubt on colorectal adjuvant therapy. , 1995, Journal of the National Cancer Institute.
[33] C. Tangen,et al. Fluorouracil plus Levamisole as Effective Adjuvant Therapy after Resection of Stage III Colon Carcinoma: A Final Report , 1995, Annals of Internal Medicine.
[34] Marco Lorenzi,et al. Folinic acid and 5-fluorouracil as adjuvant chemotherapy in colon cancer. , 1994, Gastroenterology.
[35] J. Habrand,et al. No benefit of ifosfamide in Ewing's sarcoma: a nonrandomized study of the French Society of Pediatric Oncology. , 1992, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[36] J. Krischer,et al. Expression of myeloid-associated and lymphoid-associated cell-surface antigens in acute myeloid leukemia of childhood: a Pediatric Oncology Group study. , 1992, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[37] T R Fleming,et al. Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma. , 1990, The New England journal of medicine.
[38] J. Laurie,et al. Biochemical modulation of fluorouracil: evidence of significant improvement of survival and quality of life in patients with advanced colorectal carcinoma. , 1989, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[39] N. Petrelli,et al. The modulation of fluorouracil with leucovorin in metastatic colorectal carcinoma: a prospective randomized phase III trial. Gastrointestinal Tumor Study Group. , 1989, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[40] P. Chapuis,et al. The prognostic value of substaging colorectal carcinoma. A prospective study of 1117 cases with standardized pathology , 1987, Cancer.
[41] R C Newland,et al. Terminology and classification of colorectal adenocarcinoma: the Australian clinico-pathological staging system. , 1983, The Australian and New Zealand journal of surgery.
[42] P. Chapuis,et al. The relationship of survival to staging and grading of colorectal carcinoma: A prospective study of 503 cases , 1981, Cancer.
[43] M. Orditura,et al. Is complete mesocolic excision with central vascular ligation safe and effective in the surgical treatment of right-sided colon cancers? A prospective study , 2013, International Journal of Colorectal Disease.
[44] N. Wolmark,et al. Randomized trial of adjuvant therapy in colon carcinoma: 10-year results of NSABP protocol C-01. , 2004, Journal of the National Cancer Institute.
[45] R. Scott,et al. Long-Term Results , 2001 .
[46] H. Wieand,et al. Controlled trial of fluorouracil and low-dose leucovorin given for 6 months as postoperative adjuvant therapy for colon cancer. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[47] K. Tiver,et al. Should patients with Dukes' C colon cancer receive adjuvant chemotherapy after curative resection? , 1991, The Australian and New Zealand journal of surgery.
[48] Adjuvant therapy for patients with colon and rectum cancer. , 1990, Consensus statement. National Institutes of Health Consensus Development Conference.